Cantex also plans to initiate Phase 2 clinical trials exploring the therapeutic effect of azeliragon in pancreatic and breast cancers.
By connecting a leading LongBio VC to the DeSci (decentralized science) movement, this partnership is a major milestone for the greater decentralized ecosystem
The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
This next-generation CAR T construct was designed to improve the tolerability profile of conventional CD19 CAR Ts and developed in the laboratory of James N. Kochenderfer, M.D., at the National Cancer Institute, part of the NIH, the same laboratory that discovered axicabtagene ciloleucel
ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
SPARC will pay Biomodifying a percentage of payments received for sublicenses of the licensed IP
Subscribe To Our Newsletter & Stay Updated
